Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra.
Equity benchmark indices swung higher during early hours on Thursday following a spurt in Asian markets with banking stocks taking a lead.
Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate COVID-19 disease, it added.
Equity benchmark indices swung nearly 1 per cent lower during the afternoon session on July 30 ahead of the expiry day of monthly futures and options contracts.
Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million.
"With the approval of Ilumya and our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque psoriasis," Sun Pharma North America president said.
The drug major had reported net profit of Rs 1,471.82 crore in the October-December quarter of 2016-17.
Drug major Sun Pharmaceutical Industries Ltd has inked a deal to acquire Russian pharma company JSC Biosintez for $24 million (Rs 164 crore). The move will increase Sun Pharma's presence in Russia through local manufacturing
Mumbai: The US drug regulatory agency, the Food and Drugs Administration (FDA), has warned Sun Pharma, India's biggest drug-manufacturing company, for lapses it observed at its key facility in Halol during an inspection in September
New Delhi: Sun Pharmaceutical Industries today said that its merger with Ranbaxy has been 'consummated' following receipt of requisite approvals, almost a year it announced the $4 billion deal.In a filing to the BSE, the
Mumbai: Sun Pharmaceutical Industries has acquired multinational drug maker GlaxoSmithKline's opiates business in Australia. However, the deals of the deal have not been disclosed.GSK's out-going product portfolio consists of poppy-derived opiate raw materials that are
Mumbai: If one goes by the promoter holdings in the companies listed under Bombay Stock Exchange (BSE) then Dilip Shanghvi, the promoter of Sun Pharma will appear to be the richest man in India.With this,
New Delhi: Sun Pharma on Thursday said its consolidated net profit rose by 15 per cent to Rs 1,572 crore for the second quarter ended September 30.The drug major had posted a net profit of
Mumbai: Shares of Sun Pharmaceuticals gained as much as 4.5 per cent in trade on Monday to hit its life-time high of Rs 932, after its subsidiary Taro Pharmaceuticals reported strong set of results for
Washington: India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers that are being probed by the US Congress over price escalation of generic drugs.In letters sent by Elijah E Cummings (Ranking
Mumbai: Sun Pharmaceutical Industries slumped as much as 6 percent, heading towards its biggest single-day fall since March 16, 2012.Ranbaxy Laboratories also fell as much as 6 per cent.Media reports say there was a surprise
New Delhi: Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today said it has prima facie found that the USD 4-billion merger of Ranbaxy Labs into rival Sun
Hyderabad: The Andhra Pradesh High Court today vacated a status quo order it had issued earlier on Sun Pharma-Ranbaxy merger process, paving the way for the pharma giants becoming a single entity.While vacating the status
New Delhi: The Supreme Court today asked the Andhra Pradesh High Court, which had passed an interim order staying the $4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two days.Hearing
Top News
Latest News
